The outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently declared a pandemic by the World Health Organization. In addition to its acute respiratory manifestations, SARS-CoV-2 may also adversely affect other organ systems. To date, however, there is a very limited understanding of the extent and management of COVID-19-related conditions outside of the pulmonary system. This narrative review provides an overview of the current literature about the extrapulmonary manifestations of COVID-19 that may affect the urinary, cardiovascular, gastrointestinal, hematological, hematopoietic, neurological, or reproductive systems. This review also describes the current understanding of the extrapulmonary complications caused by COVID-19 to improve the management and prognosis of patients with COVID-19.
CITATION STYLE
Zheng, K. I., Feng, G., Liu, W. Y., Targher, G., Byrne, C. D., & Zheng, M. H. (2021, January 1). Extrapulmonary complications of COVID-19: A multisystem disease? Journal of Medical Virology. John Wiley and Sons Inc. https://doi.org/10.1002/jmv.26294
Mendeley helps you to discover research relevant for your work.